This is the authors' abstract. We don't add key points for this paper.
. This proposed ECL sensor exhibits high stability, good selectivity, and reproducibility, which offers a new insight into the fabrication of immunoassays for detecting other relevant biomarkers, and it has the potential for a reliable point-of-care diagnostics of tumor or other diseases.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: